State Of Wisconsin Investment Board Nymox Pharmaceutical Corp Transaction History

State Of Wisconsin Investment Board

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$1.33 - $2.12 $59,318 - $94,552	-44,600 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$1.57 - $2.71 $16,014 - $27,642	10,200 Added 29.65%	44,600 $88,000
Q4 2018 Feb 11, 2019	BUY	$1.31 - $2.53 $16,244 - $31,371	12,400 Added 56.36%	34,400 $45,000
Q3 2017 Nov 01, 2017	BUY	$3.36 - $4.02 $73,920 - $88,439	22,000	22,000 $84,000

150K

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.